Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to learn whether our own made predictive algorithm can be used as a clinical practical decision support for patients with NSCLC spinal metastasis. The scoring system consists of the use of EGFR-TKI, KPS, Age, SCC, CA125 and smoking history. By predicting survival doctors could determine which patients are suitable for palliative therapy.


Clinical Trial Description

Investigators have performed a retrospective study on 176 patients with NSCLC spinal metastasis under the oversight of hospital's ethics committee, and investigators found that the use of EGFR-TKI, KPS, Age, SCC, CA125 and smoking history had significant association with survival. Then investigators built a simple, easy to use scoring system based on the features mentioned above. The score was calculated as 1 (for patients didn't receive EGFR-TKI), +2 (for KPS <50%), +1 (for KPS 50-70%), +1 (Age >60years), 2 (SCC ≥1.5ng/ml), +3 (CA125 ≥35 U/ml), +1 (smoking history 1-10/day), +2 (smoking history >10/day), and 0 otherwise. This algorithm was used to divide the patients into low risk (0-3), intermediate risk (4-6), high risk groups (7-10) to predict survival and determine which patients are suitable for palliative therapy. Now investigators wish to register this study to do a further research, in order to verify the accuracy and sensitivity of this algorithm. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03363685
Study type Observational
Source Ruijin Hospital
Contact
Status Recruiting
Phase
Start date November 1, 2017
Completion date November 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT01347307 - Stereotactic Body Radiotherapy for Spine Tumors N/A
Terminated NCT00593320 - Stereotactic Radiosurgery (SRS) for Spine Metastases N/A
Recruiting NCT05575323 - Randomized Trial on Same-day SBRT and Surgical Stabilization for Symptomatic Spinal Metastases N/A
Completed NCT02987153 - Kypho-Intra Operative Radiation Therapy (IORT) for Localized Spine Metastasis, Phase I/II Study N/A
Terminated NCT02407795 - Conventional With Stereotactic Radiotherapy for Pain Reduction and Quality of Life in Spinal Metastases N/A
Completed NCT01365715 - Preoperative Embolization in Surgical Treatment of Spinal Metastases. N/A
Recruiting NCT04863612 - SBRT in the Management of Solid Spinal Metastases
Not yet recruiting NCT04242589 - Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal Lesions Phase 2
Recruiting NCT01849510 - Efficacy of Dose Intensified Radiotherapy of Spinal Metastases by Hypofractionated Radiation and IGRT hfSRT Mediated Boost Phase 2
Not yet recruiting NCT06244264 - The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis N/A
Not yet recruiting NCT06220071 - Multicentric European Study In Patients With Vertebral Metastases
Completed NCT01290562 - Stereotactic Body Radiotherapy (SBRT) for Spinal/Para-Spinal Metastases (Spine SBRT) Phase 2
Recruiting NCT06120426 - En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.
Completed NCT03224650 - Validation of Novel Predictive Score for Patients With Spinal Metastases
Completed NCT02512965 - Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases N/A
Not yet recruiting NCT06093854 - Intraoperative Radiotherapy in Treating Spinal Metastases N/A
Completed NCT02364115 - Randomized Trial Comparing Conventional Radiotherapy With Stereotactic Radiotherapy in Patients With Bone Metastases - VERTICAL Study N/A
Recruiting NCT03398915 - The European Robotic Spinal Instrumentation (EUROSPIN) Study
Not yet recruiting NCT05173467 - Robot-assisted Invasion-controlled Surgery Versus Traditional-open Surgery Against Metastatic Spinal Tumor N/A
Recruiting NCT04248543 - Quantitative MRI for Functional Assessment Following SBRT for Spinal Metastases N/A